Cargando…
Uncovering Pathways to Personalized Therapies in Type 1 Diabetes
The goal of personalized medicine is to match the right drugs to the right patients at the right time. Personalized medicine has been most successful in cases where there is a clear genetic linkage between a disease and a therapy. This is not the case with type 1 diabetes (T1D), a genetically comple...
Autores principales: | Linsley, Peter S., Greenbaum, Carla J., Nepom, Gerald T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980192/ https://www.ncbi.nlm.nih.gov/pubmed/33741606 http://dx.doi.org/10.2337/db20-1185 |
Ejemplares similares
-
Through the Fog: Recent Clinical Trials to Preserve β-Cell Function in Type 1 Diabetes
por: Greenbaum, Carla J., et al.
Publicado: (2012) -
A Key to T1D Prevention: Screening and Monitoring Relatives as Part of Clinical Care
por: Greenbaum, Carla J.
Publicado: (2021) -
Antigen-Based Therapy for the Treatment of Type 1 Diabetes
por: Tian, Jide, et al.
Publicado: (2009) -
It’s Time to Bring Dendritic Cell Therapy to Type 1 Diabetes
por: Creusot, Rémi J., et al.
Publicado: (2014) -
Hypoglycemia in Type 1 Diabetes
por: McCrimmon, Rory J., et al.
Publicado: (2010)